Organization
The University of Chicago Medicine Center for Advanced Care at Orland Park
18 abstracts
Abstract
PRE-ISPY phase I/Ib oncology platform program (PRE-I-SPY-P1).Org: The University of Chicago Medicine Center for Advanced Care at Orland Park, Quantum Leap Healthcare Collaborative,
Abstract
Features of HPV+ OPSCC predictive of recurrence identified by transcriptional profiling of a case-control cohort.Org: University of Pennsylvania, The University of Chicago Medicine Center for Advanced Care at Orland Park,
Abstract
Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study)Org: The University of Chicago Medicine Center for Advanced Care at Orland Park, University of Michigan,
Abstract
Saliva-based detection of oral HPV and oral cancer.Org: The University of Chicago Medicine Center for Advanced Care at Orland Park, University of Chicago, Department of Medicine, Icahn School of Medicine at Mount Sinai, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,
Abstract
Familial disclosure of mutational status and cascade testing: Relationships with cancer-predisposing genes and race/ethnicity.Org: Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, IL, The University of Chicago Medicine Center for Advanced Care at Orland Park, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL,
Abstract
Usability and feasibility of the open-source GeRI platform for remote assessments in older adults with prostate cancer.Org: The University of Chicago Medicine Center for Advanced Care at Orland Park, Chicago, IL, Il-Yang Pharmaceuticals,
Abstract
RT-PACE: Phase I/II study of adjuvant whole pelvic hypofractionated radiotherapy for non-metastatic cervical and endometrial cancer.Org: University of Chicago, University of Utah, Hunstman Cancer Institute at the University of Utah, The University of Chicago Medicine Center for Advanced Care at Orland Park,
Abstract
Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response stratified chemoradiotherapy (CRT) for locoregional HPV16+ oropharyngeal cancer (OPC).Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, University of Chicago, The University of Chicago Medicine Center for Advanced Care at Orland Park, University of Chicago Medical Center, Chicago, IL,
Abstract
Phase I trial of enzalutamide (Enz) plus the glucocorticoid receptor antagonist relacorilant (Rela) for patients with metastatic castration resistant prostate cancer.Org: University of Chicago Medical Center, Chicago, IL, Chicago, IL, Northwestern Medicine Cancer Center Warrenville, University of Chicago, The University of Chicago Medicine Center for Advanced Care at Orland Park,
Abstract
Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer.Org: University of Chicago Medical Center, Chicago, IL, University of Kansas Medical Center, Department of Biostatistics & Data Science, University of Kansas Medical Center (KUMC), Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, University of Chicago,
Abstract
Understanding patient acceptance and compliance of a blood-based colorectal cancer screening test.Org: The University of Chicago Medicine Center for Advanced Care at Orland Park, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
Nominating molecular/immunologic drivers of central nervous system (CNS) metastases in squamous cell carcinoma of the head/neck (SCCHN).Org: Pritzker School of Medicine, The University of Chicago Medicine Center for Advanced Care at Orland Park, MD Anderson Hematology/Oncology Fellowship, Canter for Head and Neck Oncology, Dana-Farber Cancer Institute,
Abstract
Validation of a breast cancer polygenic risk score in 15,490 Brazilians using exome sequencing.Org: Mendelics, Instituto D’Or de Pesquisa e Ensino (IDOR), Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, IL, The University of Chicago Medicine Center for Advanced Care at Orland Park, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL,
Abstract
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer.Org: University of Chicago Medicine, The University of Chicago Medicine Center for Advanced Care at Orland Park, University of Chicago, UT Southwestern Medical Center, Center for Data Intensive Science at the University of Chicago,
Abstract
Prevalence of and racial/ethnic distribution of full-body skin examination among sexual and gender minority patients.Org: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, The University of Chicago Medicine Center for Advanced Care at Orland Park, Pritzker School of Medicine, University of Chicago, Division of Dermatology,
Abstract
Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study.Org: Memorial Sloan-Kettering Cancer Center, Knapp Center for Biomedical Discovery, The University of Chicago Medicine Center for Advanced Care at Orland Park, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Thoraxklinik,
Abstract
Racial differences in patterns of clinical trial discussion and participation among breast cancer patients at the University of Chicago.Org: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, The University of Chicago Medicine Center for Advanced Care at Orland Park, Chicago, IL, Section of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai,
Abstract
Introducing yttrium-90 radioembolization to atezolizumab and bevacizumab regimen for intermediate and advanced stage hepatocellular carcinoma: A preliminary report of safety and effectiveness.Org: University of Chicago Medical Center, Chicago, IL, Chicago, IL, Ascension Providence Hospital, Southfield, MI, University of Chicago,